# CodeStroke Pro - Clinical Workflow Documentation

## Overview

CodeStroke Pro is a comprehensive clinical decision support tool for acute stroke thrombolytic therapy. It follows evidence-based guidelines and provides a structured, step-by-step workflow to optimize patient care and reduce door-to-needle times.

## Clinical Workflow Steps

### 1. Last Known Well (LKW) Time Entry

**Clinical Purpose**: Establish the critical 4.5-hour window for thrombolytic therapy

-   **Input**: Time when patient was last seen without neurological symptoms
-   **Validation**: Automatically handles time zone considerations and prevents future times
-   **Clinical Significance**: Determines eligibility for IV thrombolytics (4.5-hour window)

### 2. Code Stroke Timer Activation

**Clinical Purpose**: Track door-to-needle time and maintain situational awareness

-   **4.5-Hour Window Timer**: Countdown from LKW time to thrombolytic window expiration
-   **Door-to-Needle Timer**: Tracks time from ED arrival to treatment decision
-   **Visual Indicators**: Clear, persistent display of both timers with color-coded alerts
-   **Clinical Goal**: Achieve door-to-needle time <60 minutes (AHA/ASA guidelines)

### 3. Eligibility Screening

**Clinical Purpose**: Systematic assessment of contraindications and clinical criteria

#### Absolute Contraindications (Any "Yes" excludes therapy):

-   Age <18 years
-   Intracranial hemorrhage on CT
-   Symptom onset >4.5 hours ago

#### Relative Contraindications (Require clinical judgment):

-   Blood pressure >185/110 mmHg
-   Blood glucose <50 or >400 mg/dL
-   Rapidly improving symptoms
-   Minor symptoms (NIHSS <4)
-   Current anticoagulation/antiplatelet therapy
-   Recent surgery or bleeding history
-   Other clinical contraindications

**Clinical Decision Support**:

-   Eligible: Proceed to drug selection
-   Relative contraindications: Careful risk-benefit analysis
-   Absolute contraindications: Consider alternative therapies

### 4. Drug Selection

**Clinical Purpose**: Choose appropriate thrombolytic agent based on evidence and clinical factors

#### Tenecteplase (TNK):

-   **Advantages**: Single bolus administration, potentially superior for large vessel occlusions
-   **Dosing**: 0.25 mg/kg (max 25 mg)
-   **Administration**: IV push over 5-10 seconds
-   **Clinical Consideration**: Preferred for suspected large vessel occlusion

#### Alteplase (tPA):

-   **Advantages**: Extensive clinical experience, gold standard in trials
-   **Dosing**: 0.9 mg/kg (max 90 mg)
-   **Administration**: 10% bolus + 90% infusion over 60 minutes
-   **Clinical Consideration**: Well-established safety profile

### 5. Dosing Calculator

**Clinical Purpose**: Ensure accurate, weight-based dosing with waste minimization

#### Safety Features:

-   Weight unit conversion (kg/lbs)
-   Maximum dose limits
-   Vial size optimization
-   Waste calculation and documentation
-   Downloadable dosing card for verification

#### Clinical Verification:

-   Double-check calculations with second clinician
-   Verify patient weight and drug selection
-   Document waste according to institutional policy

### 6. Clinical Resources & Post-Treatment

**Clinical Purpose**: Provide quick access to guidelines and monitoring protocols

#### Essential Resources:

-   AHA/ASA stroke guidelines
-   Emergency contacts and protocols
-   Quality improvement measures

#### Post-Thrombolytic Monitoring:

-   Neurological assessments every 15 minutes × 2 hours
-   Vital signs monitoring
-   Blood pressure management (<180/105 mmHg)
-   Bleeding precautions
-   No anticoagulants/antiplatelets × 24 hours

## Clinical Validation

### Evidence Base:

-   2019 AHA/ASA Guidelines for Early Management of Acute Ischemic Stroke
-   Recent TNK vs. tPA clinical trials (EXTEND-IA TNK, TASTE)
-   Door-to-needle time optimization studies

### Quality Metrics:

-   Door-to-needle time <60 minutes
-   Appropriate patient selection
-   Medication safety and dosing accuracy
-   Post-treatment monitoring compliance

## Safety Features

### Built-in Safeguards:

1. **Timer Persistence**: Warnings about page closure affecting timers
2. **Dose Verification**: Mandatory double-check prompts
3. **Contraindication Alerts**: Clear visual indicators for safety concerns
4. **Documentation**: Downloadable treatment cards for record-keeping

### Clinical Decision Support:

-   Step-by-step workflow prevents missed assessments
-   Visual progress tracking ensures complete evaluation
-   Evidence-based guidance at each decision point
-   Resource links for additional clinical support

## Technical Implementation

### Component Architecture:

-   **Modular Design**: Each workflow step is a separate component
-   **State Management**: Centralized timer and patient data management
-   **Real-time Updates**: Live timer displays with second-by-second accuracy
-   **Mobile Responsive**: Optimized for use on various devices

### Clinical Integration:

-   Institutional branding and funding acknowledgment
-   Emergency contact integration
-   Quality measure tracking
-   Regulatory compliance features

## Future Enhancements

### Planned Features:

-   Integration with electronic health records (EHR)
-   Automatic documentation generation
-   Quality metrics dashboard
-   Multi-language support
-   Offline capability for network outages

### Clinical Validations:

-   Ongoing validation studies
-   User feedback integration
-   Continuous guideline updates
-   Performance metric tracking

---

_This tool is developed for educational and clinical decision support purposes. Always verify calculations and consult current guidelines before patient treatment._
